These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers. Iasella SV; Stetten AZ; Corcoran TE; Garoff S; Przybycien TM; Tilton RD J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):212-220. PubMed ID: 29053080 [TBL] [Abstract][Full Text] [Related]
5. Surface tension gradient driven spreading on aqueous mucin solutions: a possible route to enhanced pulmonary drug delivery. Koch K; Dew B; Corcoran TE; Przybycien TM; Tilton RD; Garoff S Mol Pharm; 2011 Apr; 8(2):387-94. PubMed ID: 21250745 [TBL] [Abstract][Full Text] [Related]
7. Surfactant-induced Marangoni transport of lipids and therapeutics within the lung. Stetten AZ; Iasella SV; Corcoran TE; Garoff S; Przybycien TM; Tilton RD Curr Opin Colloid Interface Sci; 2018 Jul; 36():58-69. PubMed ID: 30147429 [TBL] [Abstract][Full Text] [Related]
8. Enhancing the Spreading Behavior on Pulmonary Mucus Mimicking Subphase via Catanionic Surfactant Solutions: Toward Effective Drug Delivery through the Lungs. Alp G; Aydogan N Mol Pharm; 2018 Mar; 15(3):1361-1370. PubMed ID: 29436839 [TBL] [Abstract][Full Text] [Related]
9. Postdeposition dispersion of aerosol medications using surfactant carriers. Marcinkowski AL; Garoff S; Tilton RD; Pilewski JM; Corcoran TE J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):361-70. PubMed ID: 18800882 [TBL] [Abstract][Full Text] [Related]
10. Imaging the postdeposition dispersion of an inhaled surfactant aerosol. Corcoran TE; Thomas KM; Garoff S; Tilton RD; Przybycien TM; Pilewski JM J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):290-6. PubMed ID: 22393908 [TBL] [Abstract][Full Text] [Related]
11. Effect of a Surfactant Additive on Drug Transport and Distribution Uniformity After Aerosol Delivery to Hages ND; Sembrat JC; Weber L; Johnston DJ; Stetten AZ; Sauleda M; Mulhern B; Tilton RD; Garoff S; Rojas M; Corcoran TE J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):146-153. PubMed ID: 34647795 [No Abstract] [Full Text] [Related]
12. Surfactant spreading on a deep subphase: Coupling of Marangoni flow and capillary waves. Sauleda ML; Hsieh TL; Xu W; Tilton RD; Garoff S J Colloid Interface Sci; 2022 May; 614():511-521. PubMed ID: 35121509 [TBL] [Abstract][Full Text] [Related]
13. Surfactant Driven Marangoni Spreading in the Presence of Predeposited Insoluble Surfactant Monolayers. Sauleda ML; Chu HCW; Tilton RD; Garoff S Langmuir; 2021 Mar; 37(11):3309-3320. PubMed ID: 33689367 [TBL] [Abstract][Full Text] [Related]
14. In vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways. Goikoetxea E; Murgia X; Serna-Grande P; Valls-i-Soler A; Rey-Santano C; Rivas A; Antón R; Basterretxea FJ; Miñambres L; Méndez E; Lopez-Arraiza A; Larrabe-Barrena JL; Gomez-Solaetxe MA PLoS One; 2014; 9(9):e106835. PubMed ID: 25211475 [TBL] [Abstract][Full Text] [Related]
15. Inhaled Aerosol Distribution in Human Airways: A Scintigraphy-Guided Study in a 3D Printed Model. Verbanck S; Ghorbaniasl G; Biddiscombe MF; Dragojlovic D; Ricks N; Lacor C; Ilsen B; de Mey J; Schuermans D; Underwood SR; Barnes PJ; Vincken W; Usmani OS J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):525-533. PubMed ID: 27337643 [TBL] [Abstract][Full Text] [Related]
16. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application. Kolanjiyil AV; Kleinstreuer C; Sadikot RT Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120 [TBL] [Abstract][Full Text] [Related]
17. Surfactant solutions and porous substrates: spreading and imbibition. Starov VM Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660 [TBL] [Abstract][Full Text] [Related]
18. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate. Laube BL; Jashnani R; Dalby RN; Zeitlin PL Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679 [TBL] [Abstract][Full Text] [Related]
19. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. Biddiscombe MF; Meah SN; Underwood SR; Usmani OS J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048 [TBL] [Abstract][Full Text] [Related]
20. Deposition of Aerosolized Lucinactant in Nonhuman Primates. Gregory TJ; Irshad H; Chand R; Kuehl PJ J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):21-33. PubMed ID: 31436493 [No Abstract] [Full Text] [Related] [Next] [New Search]